Current filters:  
UK
Healthcare
Life Sciences, Biotechnology & Nanotechnology
European Union
Cooley LLP
Big day today for products law in the UK. With 4 months until the end of the UK's transition period out of the EU, the UK government has issued guidance here on placing manufactured goods...
Veale Wasbrough Vizards
The Association of the British Pharmaceutical Industry (ABPI) Code of Practice is currently in a review and update process, intended to produce a revised version of the Code which will have...
UK
Veale Wasbrough Vizards
The UK marked its place as the frontrunner in the field of genomics many years ago when it created genomics focused institutions such as the UK BioBank and Genomics England...
Veale Wasbrough Vizards
Stevenage has been classified by the Department for International Trade (DIT) as a High Potential Opportunity (HPO) zone in recognition of its leading cell and gene therapy cluster.
Veale Wasbrough Vizards
Many in the pharma and life sciences sector have expressed concern over the seemingly low prospects of a trading deal between the EU and UK after the end of the Brexit transition period...
Veale Wasbrough Vizards
A wide variety of products currently sold in the UK are required to bear a 'CE' marking to show their conformity with various legal requirements.
Taylor Vinters
The Life Sciences sector has not been as newsworthy, pressured and flush with investors in living memory.
Leigh Day
Tornier SAS, the manufacturer of the Insypre ™ shoulder prosthesis, published a Field Safety Notice on 23 September 2020 to alert physicians to changes for its use.
Leigh Day
As the third annual Women's Rights in Healthcare event moved online this year, in the form of weekly webinars throughout autumn, the first in the series took a closer look at the Cumberlege Review and discussed the ‘First Do No Harm' report.
HGF Ltd
The Legal 500 has been analysing the capabilities of law firms across the world, with a comprehensive research programme revised and updated every year to bring ...
Cooley LLP
The MHRA has established five strategic goals for 2020-21 that will impact all those operating in the UK medicines and medical devices industries
Veale Wasbrough Vizards
During the current coronavirus (COVID-19) pandemic, pharmaceutical companies have been in the headlines on a regular basis, and none more so than AstraZeneca.
Veale Wasbrough Vizards
The Department of Health and Social Care (DHSC) has asked suppliers of medicines and medical products in the UK to stockpile six weeks' worth of stock on UK soil to prepare for the end of the...
Cleary Gottlieb Steen & Hamilton LLP
Private equity investment slowed sharply in the first half of 2020 as a result of the impact of COVID-19.
Dehns
In this very special podcast, we take a look at the Life Sciences sector in Norway and how this is one of the country's fastest growing sectors, with innovation, funding and IP being central to this
Leigh Day
Peers called for the implementation of Baroness Cumberlege's report following the Independent Medicines and Medical Devices Safety Review...
Dehns
SPCs provide a valuable extension to patent protection in Europe for pharmaceutical, veterinary and plant protection products.
Leigh Day
The Medicines and Healthcare Regulation Authority (MHRA), the UK regulator of medicines and medical devices, has issued a Medical Device Alert (MDA) about USS II Polyaxial Heads.
Leigh Day
Groups representing families affected by the use in pregnancy of the epilepsy drug Sodium Valproate have delivered their response to the Cumberlege Review, published July 8.
Leigh Day
The safety of your unborn baby is undoubtedly of paramount importance to a woman who is considering a pregnancy.
FREE News Alerts
Sign Up for our free News Alerts - All the latest articles on your chosen topics condensed into a free bi-weekly email.
Upcoming Events
Tools
Font Size:
Translation
Mondaq Social Media